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1. Introduction 
Vascular anomalies are seen in all branches of medicine and surgery. The term vascular 
anomaly is necessarily broad, encompassing lesions of skin and viscera and excluding 
abnormalities of the heart and large arteries and veins [1]. A biologic classification of 
vascular anomalies described in 1982 by Mulliken and Glovacki, correlates the cellular 
features of vascular anomalies with clinical characteristics and natural history [1,2]. Vascular 
anomalies of infancy and childhood are divided into two major categories: 1) tumors (most 
being hemangiomas) and 2) vascular malformations [1].  
The typical infantile hemangiomas (IHs) appears postnataly and evolve through 3 
predictable stages: a rapidly proliferating stage (generally lasting 8 to 12 months), followed 
by prolonged involuting phase (1 to 7 years), entering the involuted phase characterized by 
fibrofatty residuum [1,3]. Early proliferative-stage hemangiomas are composed of well-
defined, but noncapsulated, masses of plump endothelial cells and attendant pericytes that 
form small lumina containing erythrocytes. Even in early lesional stage, endothelium posses 
immunophenotypic and ultrastructural features of mature endothelium including 
immunoreactivity for CD31, CD 34, factor VIII- related antigen Ulex europeaus lectin I, VE-
cadherin, HLA-DR, and vimentin. GLUT 1 is specific and useful immunohistochemical 
marker for hemangiomas during all phases of these lesions [3].  The typical IHs appears 
postnatally, grows rapidly, and regresses slowly. The term congenital hemangioma was 
introduced to denote a vascular tumor that had grown to its maximum size at birth and 
does not exhibit accelerated postnatal growth. There are at least two major subgroups: 
rapidly involuting congenital hemangioma (RICH), and noninvoluting congenital 
hemangioma (NICH) [4]. 
Infantile hemangiomas (IHs), are the most common benign, soft tissue tumors of infancy 
which affect between 4 and 12% of all Caucasian [1,5,6]. The prevalence among Asians and 
black infants is considerably less [5]. There is a 3:1 predilection for the female sex, and they 
are weakly associated with prematurity [6–8]. The pathophysiologic mechanisms leading to 
endothelial cells proliferation and involution are poorly understood [6,7]. Current theories 
focus on progenitor cells, development field defects, placental involvement, derangement of 
angiogenesis and mutations in the cytokine regulatory pathway [6,7]. Involution coincides 
with increased apoptosis of endothelial and stromal cells [7].  
Most IHs involve the head and neck (up to 60%) [1]. Facial IHs are associated with parental 
reactions of disbelief and fear, particularly in the growth phase. Most parents expressed a 
desire to have the hemangioma removed before the children entered school. The strangers 
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often raised the question of child abuse, and some parents indicated that their children try to 
hide their lesions from the other [8]. 
Clinical appearance allows differentiation between focal, indeterminate and segmental IHs. 
Size, location and subtype were major factors that predicted complications and need for 
treatment [9].  Focal type had a tumor-like appearance and a less common diffuse type had a 
segmental distribution pattern and plaquelike appearance. Segmental IHs exhibit worse 
prognosis with more complications (ulceration, airway obstruction) [5,9]. Although 
subglottic hemangiomas are rare, they are extremely dangerous due to their location and 
rapid growth during the proliferative phase. “Beard” distribution of hemangioma is highly 
suspected for subglottic localization of hemangioma [5,6,23].   
Most IHs are small, harmless tumors that should be allowed to involute without treatment. 
Generally, treatment is instituted for complications within the IHs itself (such as ulceration, 
bleeding, infection), or impairments caused by the hemangioma (amblyopia, impaired 
breathing, feeding difficulties, heart failure), and the wait-and-see medical management 
policy for these hemangioma should be replaced by a more active approach. [9,10]. More 
than half of IHs will involute with a poor result and therefore required a corrective surgery 
[11]. Haggstrom et al. stated that 43% patients with a facial hemangioma received treatment 
of some kind [9].   
The management of hemangioma is an area of great controversy [6]. Current options are 
conservative treatment (corticosteroids, interferons, hemiotherapy, propranolol), laser 
treatment, and surgical treatment [6,9–27]. Corticosteroids were generally accepted to be the 
first-line therapy for hemangiomas [6]. They can be used orally, intralesionally, 
intravenously or topically. Interferons were usually reserved for serious cases in which 
steroids were contraindicated, have failed, or in severe complications [12]. Unfortunately, 
severe neurotoxicity (spastic diplegia) was found to be severe adverse effect [6]. 
Antineoplastic agents were also successful in treatment of hemangioma, because of their 
proliferative nature (bleomycin, cyclophosphamide, vinristine) but this treatment should be 
reserved for infants with hemangioma demonstrating aggressive behavior characteristics 
[6]. A wide variety of lasers have been used with a broad range of results (pulse-dye, CO2). 
Externally-applied laser can penetrate only 1-2 mm into the dermis and therefore has a 
limited value for the treatment of hemangioma [1,6].  Embolisation, cryotherapy and 
compression had also been used [6,12,16,30].   
Recently propranolol proved itself effective in inducing regression of growing hemangioma. 
There are several reports confirming prompt response of hemangioma to propranolol with 
no major side effects [23,25,28,29].  
There are three questions regarding surgical intervention: 1) what are the indications, 2) 
when it should be done (timing) and 3) how it should be done [30]. Surgical excision of 
hemangioma has been usually performed by lenticular excision with a linear closure. This 
technique is useful in the eyelid, lip and neck region [30]. An alternative technique that does 
not have these disadvantages is the circular excision or by circular excision and with purse 
string closure which is now considered the first line technique at any stage of the tumors life 
cycle [11,30].   
In some children with extremely large hemangiomas, the vascularity of the lesion is also a 
significant anesthetic consideration. There is a need for particular attention to 
hemodynamic consideration with anesthesia and potential need for transfusion. 
Haemostatic squeezing suture around the hemangioma can be used prior to resection to 
avoid blood loss [23]. 
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2. Nasal hemangiomas 
Nasal hemangiomas are among the more distressing, if large, can cause a significant 
residual damage to the shape of the nose [6]. Due to their location, nasal hemangiomas are 
profoundly disturbing lesions both for patients and their families (Fig. 1). Hemangiomas 
involving the nose occur approximately 15,8% of facial hemangiomas [13].  The nasal tip is 
by far the most common site of nasal hemangiomas [11].   
 
    
 
    
Fig. 1. Different types of nasal hemangioma from small no harming, involving nasal tip, 
complicated with nasal obstruction and large superficial hemangioma 
Nasal hemangiomas can cause functional problems (nasal obstruction, alteration of the nasal 
valve, ulceration and destruction of the delicate growing cartilage of the nose) and severe 
psychological sequelae to the children because of social redicule of their peers, and also 
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from medical professionals who are using terms like “Cyrano nose, “Pinocchio nose”. 
During proliferative phase they can permanently distort nasal architecture (by displacing 
lower lateral cartilages laterally) [13-15,17]. Parent’s anxiety is something that surgeon have 
to deal with during the child growth. In most cases they are not satisfied with explanation 
that hemangioma will regress spontaneously during childhood. Aesthetic problem is 
usually obvious. Eivazi et al. classified nasal tip hemangiomas as „limited” or „advanced” 
[25]. Hamou et al. identify three types of nasal hemangiomas that lead to three distinct 
surgical approaches: 
- Type A (mild cases): no cutaneous involvement, no misalignment of the cartilages an 
mild nasal volume increase 
- Type B (moderate cases): partial cutaneous infiltration, misalignment of the cartilages 
and moderate nasal volume increase 
- Type C (severe cases): cutaneous infiltration, misalignment of the cartilages and severe 
nasal volume increase [31]. 
They are usually subcutaneous or mixed superficial and subcutaneous lesions that occupy 
the space between the skin and the nasal tip and lower lateral cartilages [15]. Nasal 
hemangioma are often slow to regress, leaving excess wrinkled nonelastic skin, residual 
fibrofatty tissue with a permanently bulbous nasal tip, visible teleangiectases or contour 
deficiencies [11,13,14,17,19,20,27].   
3. Treatment options 
The treatment of nasal hemangiomas is extremely difficult because of its location and 
possible complications [31]. In most of these cases expectation is not a treatment option. 
There is a pressure from the family to improve the child’s appearance. 
Numerous medical and surgical treatment approaches have been proposed for the 
treatment of these tumors. The treatment choices of nasal hemangiomas are still 
controversial considering use of preoperative medical treatment, timing of surgery, surgical 
approach and necessity of skin resection [15, 27].  
Pharmacological, surgical or laser interventions are current treatment options for nasal 
hemangiomas [13-27].  
A „no-touch” or conservative approach for the treatment of nasal hemangiomas was 
previously advocated with frequent consultations with the parents to furnish psychological 
support [26].            
Advocates of conservative treatment claim that resection causes growth disturbances in 
nasal architecture [14,16]. Denk et al. consider that conservative treatment should be 
reserved for small hemangiomas on the nose that are not deforming and are without 
complications [17]. Corticosteroids were, for the long period, the first line treatment for 
nasal hemangioma with excellent results in 30% of cases [13,18]. Interferon was usually 
reserved for life threatening lesions resistant to steroids [13]. Because of the possible 
complications (skin atrophy) Hochman and Mascareno have moved away from using local 
steroid injections for nasal hemangioma [22].  
Because of convincing results, beta blockers are preferred as the first treatment option for 
proliferating hemangioma [25,28,29,31]. Proponents of early surgery suggest that aesthetic 
and functional improvement during a critical period in child development can be achieved 
[13-17].  
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Laser is indicated only for the treatment of the involuting hemangioma, and it is not helpful 
for the deeper components [12,16].  
4. Surgical treatment 
Thomson et al. have been treated eleven patients with different surgical approaches. Several 
procedures had been carried out on each patient (an average of 4 operations on one patient) 
with 50% delayed primary healing, especially in earlier operated patients [26]. 
Van der Meulen et al. moved away from „no touch” approach, and they stated „that there 
is no need to wait with effective treatment until involution has stopped”. They had 9 
patients operated with low-flying bird incision (Rethi incision), and with so called „L-
approach”, which is Rethi incision extended in cranial direction along the alar fold and 
nasomaxillary junction. They performed before school age without previous conservative 
treatment [19]. 
Pitanguy advocated an elliptical midline incision over the dorsum of the nose that can give 
good functional results but with obvious midline scar on the back of the nose, and the 
excision of the dog ear may cause extensions of the incision up into the glabellar region, 
which may lead to an unsatisfactory aesthetic result [20,24].  
Jackson presented excision of a nasal tip hemangioma via open rhinoplasty procedure, with 
step incision on columella, proceeding on both sides of columella, and continuing just inside 
the alar rims. The resection of hemangioma and fibrofatty tissue begins between the medial 
crura and continues upwards over the domes of lower lateral cartilages. The medial crura 
and the domes of the lower lateral cartilages are approximated with nonapsorbable suture. 
Intranasal incisions are closed with absorbable suture. A plaster cast was placed for seven 
days. Care must be taken not to remove too much tissue because with the time and 
continued involution, this may lead to loss of the nasal projection. The excess skin is allowed 
to contract over the time (six months) [24].  
Denk et al. used the incision made in midline, staring at the tip of the nose, extending the 
incision superiorly or inferiorly as needed. The mean age at the first operation was 2,2 years 
[17]. 
Warren et al. stated that the nose may be divided into  topographic subunits (dorsum, tip, 
alar lobules, side-walls, and soft triangles). There incision were placed along the the lines 
that separate this subunits. The incision placement in this modified subunit approach to 
nasal tip hemangiomas was at lateral aspect of the nasal dorsum and carried down around 
the tip in the declivity medial to the alar lobule and medially into the infratip intercrucial 
region [15]. 
Faguer et al. suggest for surgical treatment of nasal hemangiomas transcolumellar low-
flying bird (Rethi incision), combined with rim incision to expose alar cartilages [21]. With 
this technique they manage to excise small and large hemangiomas. Waner at al. stated that 
this approach is less appropriate for larger hemangioma, because the the incision cannot be 
extended cranially [13]. 
McCarthy et al. performed surgical resection of nasal tip hemangioma when the patients 
was over the age of 3 years for the treatment of lesions that showed no signs of regression 
over at least a 6 month period. „Open rhinoplasty approach” was used similar to Faguer et 
al. with transcolumellar incision and marginal „rim incision”. Before this haemostatic 
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sutures around the lesion were placed. If there was marked skin excess after redraping, it 
was resected, sometimes with central wedge excision [14].  
Waner et al. proposed modified subunit approach along the contour lines of nasal subunits. 
Their surgical approach is based on the principles of Burgett and Menick subunit surgery in 
reconstructive surgery of the nose, but the incision line has been modified to allow better 
access to all of nasal subunits, and to allow trimming of the excess skin after the 
hemangioma has been removed. By this technique the lower lateral cartilages are 
approximated, as well as the medial crura, narrowing the columella to achieve nasal 
projection. These author avoid placement of in incision in an anterior location due to 
aesthetic reasons, preserving if it is possible some part of the affected skin which can be 
treated by laser [13].  
Hochman and Mascareno proposed the combination of several treatment modalities. They 
use classical surgical approach based on already accepted rules, extending the incisions into 
the alar grooves or vertically along junction of the nasal tip and lobular subunits or even up 
the midline of the tip [22]. 
Vlahovic and coworkers use the open rhinoplasty incision for nasal tip, columella and alar 
subunits hemangioma and circular excision and „purse string suture” for large nasal 
hemangioma localized on the nasal dorsum with predominant deep component with 
previous medical (corticosteroid) treatment for large hemangiomas [23]. 
Eivazi et al. suggested that propranolol should be used as a treatment option for 
hemangioma of the nasal tip, and if there is indication for surgical treatment (destructive, 
highly proliferative or otherwise uncontrollable lesions) it should be conventional and made 
on the basis of the affected regions [25]. 
Arneja et al. advocate combined medical and surgical approach to treat the „Cyrano” 
nose. An open rhinoplasty approach with skin resection is the authors preferred technique 
[27]. 
Hamou et al. advocate early surgery and the operative technique was chosen based on the 
size of the lesion and the presence or absence of cutaneous infiltration. [31]. 
5. Conclusion 
The optimal treatment approach for nasal hemangiomas remains controversial. 
Management of nasal hemangiomas involves a combination of serial observation, 
conservative treatment (propranolol), and surgical therapy. 
Serial observation is indicated for small nasal hemangioma, which requires no treatment, 
but in that way we can give support and counseling to the patient and family. As the results 
after treatment of hemangioma with propranolol are encouraging, the beta blockers are 
preferred as the first treatment option for proliferating IHs, and this includes nasal 
hemangiomas also.  
In a rapidly growing hemangioma (precisely the hemangiomas that one would prefer not to 
operate upon due to increased vascularity and blood loss), the straightforward decision 
should be to give  a trial with propranolol, before embarking upon surgery. If propranolol 
fails, then surgery becomes next option.  
The treatment protocol for propranolol developed by Siegfried at al. to optimize the safety is 
as follows: baseline echocardiography and 48-hour hospitalization or home nursing visits to 
monitor vital signs and blood glucose levels, medication is given every 8 hours, with a 
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initial dose of 0,16 mg per kilogram of body weight. If the vital signs and glucose levels 
remain normal, the dose is incrementally doubled to maximum of  0,67 mg per kilogram 
(to a maximum daily dose of 2.0 mg per kilogram). This therapy should be continued 
through the proliferative phase of haemangioma growth or until no further improvement 
occurs. Instead of abrupt discontinuation a gradual tapering of propranolol over 2–3 
weeks is recommended. If a rebound effect occurs patients are placed back on propranolol 
[29]. 
Different surgical procedures have been suggested for the treatment of nasal hemangiomas 
depending on the size and location of hemangioma (Fig.2). Surgery had to be performed 
 
 
 
 
Fig. 2. Preoperative nasal hemangioma and result two years after open rhinotomy excision 
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under general anesthesia, with local infiltration of 1:100,000 adrenalin at the incision 
place. The selection of the optimal surgical approach should be made carefully on the 
basis of the affected regions. An open rhinoplasty approach, with or without skin 
resection, should be preferred technique for the lesion that involved nasal tip, columella 
and alar subunits, and in if wider approach is needed the nasal subunits had to be 
respected (Fig.3). 
 
  
 
 
Fig. 3. Intraoperativne result after excision of nasal hemangioma with open rhinoplasty 
approach 
Considering the timing of the surgery, early surgery at the end of the proliferative phase 
and during second year of life with maximum preservation of the tissue is appropriate 
because psychosocial, aesthetic and functional problems can be avoided.  Surgical removal 
of nasal hemangioma should be delayed until the hemangioma has stopped proliferating. 
Surgical treatment during involutional phase is technically easier. 
If there are no possibilities for total excision of hemangioma it can be reduced to an 
acceptable level avoiding destruction of the nasal tissue. 
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Subtotal excision for large hemangioma, without all of the affected skin, which will fade in 
the involutive phase, avoiding visible scars, by placing the incision along the columellar 
edge and parallel to the nostril is appropriate approach (Fig.4).  
 
   
 
   
Fig. 4. Circular excision and „purse string suture” technique for large nasal hemangioma 
If deep component of hemangioma is predominant, and hemangioma is mostly placed on 
the nasal dorsum, a circular excision and „purse string suture” technique will be 
appropriate because of „tissue expander” effect of hemangioma (Fig.5). The scar by this 
technique is more acceptable comparing to lenticular excision especially for large 
hemangiomas.  
Surgery will retain its importance in cases of non responders to beta blockers, or the 
theoretical remaining deformity caused by the residual hemangioma or remnant fibrous 
fatty tissue after hemangiomas regression. 
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Fig. 5. Excision of large nasal hemangioma with open rhinoplasty approach, minimal tissue 
removing, result after two years 
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